Pages that link to "Q34631580"

The following pages link to Role for the membrane receptor guanylyl cyclase-C in attention deficiency and hyperactive behavior (Q34631580):

Displaying 44 items.

• From Escherichia coli heat-stable enterotoxin to mammalian endogenous guanylin hormones (Q27025808) (← links)
• GUCY2C opposes systemic genotoxic tumorigenesis by regulating AKT-dependent intestinal barrier integrity (Q27308895) (← links)
• Abnormal behaviors and developmental disorder of hippocampus in zinc finger protein 521 (ZFP521) mutant mice (Q30440967) (← links)
• High stakes trigger the use of multiple memories to enhance the control of attention (Q33872224) (← links)
• Characterization of immunological cross-reactivity between enterotoxigenic Escherichia coli heat-stable toxin and human guanylin and uroguanylin (Q33899693) (← links)
• Attention as an effect not a cause (Q34293747) (← links)
• Effect of guanylate cyclase-C activity on energy and glucose homeostasis (Q34393417) (← links)
• Regulation of hippocampal synaptic plasticity thresholds and changes in exploratory and learning behavior in dominant negative NPR-B mutant rats. (Q34597060) (← links)
• Circadian modulation of dopamine levels and dopaminergic neuron development contributes to attention deficiency and hyperactive behavior (Q35069738) (← links)
• BDNF interacts with endocannabinoids to regulate cocaine-induced synaptic plasticity in mouse midbrain dopamine neurons. (Q35164109) (← links)
• Guanylyl cyclases A and B are asymmetric dimers that are allosterically activated by ATP binding to the catalytic domain (Q35543592) (← links)
• Identification of embryonic stem cell-derived midbrain dopaminergic neurons for engraftment (Q36129036) (← links)
• Natriuretic peptides block synaptic transmission by activating phosphodiesterase 2A and reducing presynaptic PKA activity. (Q36378347) (← links)
• Pharmacology and clinical potential of guanylyl cyclase C agonists in the treatment of ulcerative colitis (Q36790193) (← links)
• GUCY2C ligand replacement to prevent colorectal cancer. (Q37146309) (← links)
• Guanylin and uroguanylin are produced by mouse intestinal epithelial cells of columnar and secretory lineage (Q37284644) (← links)
• Guanylate cyclase C deficiency causes severe inflammation in a murine model of spontaneous colitis (Q37296767) (← links)
• Dicer expression is essential for adult midbrain dopaminergic neuron maintenance and survival (Q37621936) (← links)
• Adult attention deficit hyperactivity disorder: translating research into practice (Q37986704) (← links)
• The multiple and enigmatic roles of guanylyl cyclase C in intestinal homeostasis (Q38028211) (← links)
• Understanding the mechanisms of cognitive impairments in developmental coordination disorder (Q38160153) (← links)
• Natriuretic hormones in brain function (Q38288274) (← links)
• Molecular Physiology of Membrane Guanylyl Cyclase Receptors (Q38794203) (← links)
• Guanylyl Cyclase C Hormone Axis at the Intersection of Obesity and Colorectal Cancer (Q38850722) (← links)
• A preliminary study on methylphenidate-regulated gene expression in lymphoblastoid cells of ADHD patients (Q38962446) (← links)
• Preclinical Evaluation of a Replication-Deficient Recombinant Adenovirus Serotype 5 Vaccine Expressing Guanylate Cyclase C and the PADRE T-helper Epitope (Q39142095) (← links)
• Site-specific N-linked glycosylation of receptor guanylyl cyclase C regulates ligand binding, ligand-mediated activation and interaction with vesicular integral membrane protein 36, VIP36. (Q39220487) (← links)
• Exploring the Validity of Proposed Transgenic Animal Models of Attention-Deficit Hyperactivity Disorder (ADHD). (Q39324205) (← links)
• Guanylyl cyclase C and guanylin reduce fat droplet accumulation in cattle mesenteric adipose tissue (Q39430494) (← links)
• Prime-Boost Immunization Eliminates Metastatic Colorectal Cancer by Producing High-Avidity Effector CD8+ T Cells (Q40274361) (← links)
• Pharmacogenetic activation of midbrain dopaminergic neurons induces hyperactivity (Q41453654) (← links)
• Synaptotagmin-11 is a critical mediator of parkin-linked neurotoxicity and Parkinson's disease-like pathology (Q47192722) (← links)
• Acute and long-term suppression of feeding behavior by POMC neurons in the brainstem and hypothalamus, respectively. (Q48155417) (← links)
• Determining an optimal dose of linaclotide for use in Japanese patients with irritable bowel syndrome with constipation: A phase II randomized, double-blind, placebo-controlled study (Q48349012) (← links)
• Deficiency of tumor suppressor NDRG2 leads to attention deficit and hyperactive behavior (Q50067883) (← links)
• Selective inhibition of intestinal guanosine 3',5'-cyclic monophosphate signaling by small-molecule protein kinase inhibitors. (Q52589288) (← links)
• High-dose linaclotide is effective and safe in patients with chronic constipation: A phase III randomized, double-blind, placebo-controlled study with a long-term open-label extension study in Japan (Q57798947) (← links)
• Translational medicine in China I: Perspectives from Chinese physicians and scientists (Q59255559) (← links)
• Split tolerance permits safe Ad5-GUCY2C-PADRE vaccine-induced T-cell responses in colon cancer patients (Q64097244) (← links)
• Immunizations with enterotoxigenic heat-stable toxin conjugates engender toxin-neutralizing antibodies in mice that also cross-react with guanylin and uroguanylin (Q64124647) (← links)
• Discovery of Novel Cell Surface Markers for Purification of Embryonic Dopamine Progenitors for Transplantation in Parkinson's Disease Animal Models (Q64869052) (← links)
• Environmental Enrichment Elicits a Transient Rise of Bioactive C-Type Natriuretic Peptide in Young but Not Aged Rats. (Q64896073) (← links)
• Gastrointestinal hormones: uroguanylin-a new gut-derived weapon against obesity? (Q82502625) (← links)
• Signatures of selection in the genome of Swedish warmblood horses selected for sport performance (Q90165639) (← links)